Chronic Paediatric Conditions — MCQs
On this page
An 8-year-old boy with focal epilepsy has been seizure-free for 30 months on lamotrigine monotherapy. His parents enquire about discontinuing anti-epileptic medication. According to current guidelines, what factor would most strongly support continuing treatment rather than attempting withdrawal at this time?
A 5-year-old girl with newly diagnosed type 1 diabetes is being discharged from hospital. Her parents are being educated about sick day management. She develops gastroenteritis with vomiting and reduced oral intake. Her blood glucose is 15.2 mmol/L and ketones are 1.8 mmol/L. What is the most appropriate immediate management advice?
A 14-year-old girl with type 1 diabetes for 6 years presents with a 3-month history of delayed gastric emptying symptoms including early satiety, bloating, and postprandial nausea. Her HbA1c is 75 mmol/mol with significant glucose variability. Examination reveals no abdominal masses. Coeliac screening is negative. What investigation would best confirm the suspected diagnosis?
A 7-year-old boy presents with episodic events described by his teacher. During class, he suddenly becomes unresponsive for approximately 10 seconds, stares blankly, and exhibits subtle eyelid fluttering. He immediately resumes his previous activity with no post-ictal confusion. These episodes occur 5-10 times daily. An EEG shows bilateral synchronous 3 Hz spike-and-wave discharges. What is the expected response to hyperventilation during EEG testing in this condition?
A 9-year-old boy with type 1 diabetes for 3 years attends his annual review. His blood tests show HbA1c of 58 mmol/mol. His mother reports that he has been experiencing morning hyperglycaemia despite good control during the day. His bedtime glucose readings are typically 6-8 mmol/L, but morning fasting glucose is 12-14 mmol/L. What phenomenon best explains his morning hyperglycaemia?
A 6-year-old girl with type 1 diabetes mellitus is being started on insulin therapy. Her parents ask about the onset of action of different insulin preparations. What is the approximate onset of action of insulin aspart?
A 16-year-old boy with type 1 diabetes for 8 years presents for routine review. His HbA1c has been suboptimal at 75-82 mmol/mol over the past year despite multiple clinic appointments. He admits to frequently missing insulin doses and not checking his blood glucose regularly. He expresses frustration with diabetes management and feeling "different" from his peers. His growth and development are normal and there are no acute complications. What is the most appropriate initial approach to improve his diabetes management?
A 11-year-old boy with refractory focal epilepsy is being evaluated for possible epilepsy surgery. He has tried four different antiepileptic drugs without adequate seizure control and experiences 2-3 seizures per week affecting his school attendance and quality of life. Video-EEG telemetry has identified a consistent seizure focus in the right frontal lobe. MRI brain shows focal cortical dysplasia in the same region. Neuropsychological testing shows age-appropriate cognitive function. Which additional investigation is most critical in determining his suitability for surgical resection?
A 4-year-old boy with newly diagnosed type 1 diabetes is being commenced on insulin therapy. His parents ask about the rationale for using rapid-acting insulin analogues (such as insulin aspart or lispro) rather than regular soluble human insulin for mealtime boluses. What is the primary pharmacokinetic advantage of rapid-acting insulin analogues in paediatric diabetes management?
A 15-year-old girl with juvenile myoclonic epilepsy has been well-controlled on sodium valproate 800 mg twice daily for 3 years. She attends clinic with her mother requesting information about future pregnancy planning. She is not currently sexually active. Understanding the teratogenic risks, which counseling point regarding valproate and pregnancy is most accurate?
Chronic Paediatric Conditions UK Medical PG Practice Questions and MCQs
Question 61: An 8-year-old boy with focal epilepsy has been seizure-free for 30 months on lamotrigine monotherapy. His parents enquire about discontinuing anti-epileptic medication. According to current guidelines, what factor would most strongly support continuing treatment rather than attempting withdrawal at this time?
- A. Presence of persistent epileptiform discharges on EEG (Correct Answer)
- B. Family history of epilepsy in a first-degree relative
- C. Age at onset of first seizure being under 2 years
- D. Previous failure of initial anti-epileptic drug requiring switch to lamotrigine
- E. History of three seizures before achieving control
Explanation: ***Presence of persistent epileptiform discharges on EEG***- A **persistent epileptiform EEG** is one of the strongest predictors of seizure recurrence, doubling the risk compared to children with a normal EEG prior to withdrawal.- Most guidelines recommend performing a **repeat EEG** before discontinuing medication to help stratify the risk of relapse after a period of seizure freedom.*Family history of epilepsy in a first-degree relative*- While **genetic predisposition** is a factor in epilepsy etiology, it is not a primary contraindication for attempting drug withdrawal after sustained seizure freedom.- Clinical status and **EEG findings** carry much more weight in predicting successful withdrawal than a family history of the condition.*Age at onset of first seizure being under 2 years*- Very early onset may sometimes be associated with **symptomatic etiologies**, but age under 2 years is not a definitive barrier to withdrawal if the child is now stable and seizure-free.- Conversely, **older age at onset** (adolescence) is often viewed as a higher risk factor for lifelong epilepsy compared to childhood-onset epilepsy.*Previous failure of initial anti-epileptic drug requiring switch to lamotrigine*- Switching medications due to **side effects** doesn't preclude withdrawal; only **refractory epilepsy** (failure to control seizures) significantly increases the risk of recurrence.- Since the patient is currently well-controlled on **monotherapy**, the history of a drug switch is less concerning than active epileptiform activity on EEG.*History of three seizures before achieving control*- A **low number of total seizures** (such as three) before achieving remission is actually a favorable prognostic indicator for successful medication withdrawal.- High seizure frequency before control or a long duration before reaching **seizure-free status** would be more indicative of the need to continue treatment.
Question 62: A 5-year-old girl with newly diagnosed type 1 diabetes is being discharged from hospital. Her parents are being educated about sick day management. She develops gastroenteritis with vomiting and reduced oral intake. Her blood glucose is 15.2 mmol/L and ketones are 1.8 mmol/L. What is the most appropriate immediate management advice?
- A. Continue usual insulin doses, encourage frequent small amounts of fluid, and check blood glucose and ketones 2-hourly (Correct Answer)
- B. Reduce insulin dose by 50%, encourage clear fluids only, and check blood glucose 4-hourly
- C. Omit insulin until she is eating normally again and monitor blood glucose 6-hourly
- D. Give an additional correction dose of rapid-acting insulin and withhold all food until vomiting settles
- E. Present immediately to emergency department for intravenous fluid therapy
Explanation: ***Continue usual insulin doses, encourage frequent small amounts of fluid, and check blood glucose and ketones 2-hourly*** - During illness, **insulin requirements** often increase due to stress hormones, making it crucial to continue usual basal insulin to prevent **diabetic ketoacidosis (DKA)**. - Frequent monitoring of **blood glucose and ketones** (every 2 hours) is vital during sick days to guide further management, including potential correction doses, and detect worsening metabolic state early. *Reduce insulin dose by 50%, encourage clear fluids only, and check blood glucose 4-hourly* - Reducing insulin doses in a child with **hyperglycemia (15.2 mmol/L)** and **ketosis (1.8 mmol/L)** is dangerous and will accelerate the progression to DKA. - **4-hourly monitoring** is insufficient for a sick child with type 1 diabetes, especially with vomiting and elevated ketones, as rapid metabolic changes can occur. *Omit insulin until she is eating normally again and monitor blood glucose 6-hourly* - **Never omit insulin** in type 1 diabetes, even with reduced oral intake, as this is a direct pathway to severe **DKA** due to the body's absolute insulin deficiency. - Monitoring **blood glucose 6-hourly** during illness is too infrequent and delays critical intervention for rapidly deteriorating metabolic status. *Give an additional correction dose of rapid-acting insulin and withhold all food until vomiting settles* - While a correction dose might be needed, **withholding all food** and fluids for an extended period in a vomiting child increases the risk of dehydration and can worsen ketosis by not providing glucose substrate. - The priority is to provide **small, frequent sips of carbohydrate-containing fluids** to maintain hydration and provide energy, even if the child is vomiting. *Present immediately to emergency department for intravenous fluid therapy* - Although concerning, her ketone level of **1.8 mmol/L** indicates moderate ketosis, which can often be managed at home initially with vigilant monitoring and oral fluids, before it progresses to severe DKA (typically >3.0 mmol/L). - Immediate emergency department presentation is typically warranted for signs of **established DKA** such as deep, rapid breathing (Kussmaul's), severe abdominal pain, persistent vomiting despite oral rehydration attempts, or altered consciousness.
Question 63: A 14-year-old girl with type 1 diabetes for 6 years presents with a 3-month history of delayed gastric emptying symptoms including early satiety, bloating, and postprandial nausea. Her HbA1c is 75 mmol/mol with significant glucose variability. Examination reveals no abdominal masses. Coeliac screening is negative. What investigation would best confirm the suspected diagnosis?
- A. Gastric emptying scintigraphy (Correct Answer)
- B. Oesophagogastroduodenoscopy with biopsy
- C. Abdominal ultrasound
- D. Hydrogen breath test
- E. Autonomic function testing
Explanation: ***Gastric emptying scintigraphy***- This is the **gold standard** for diagnosing **diabetic gastroparesis** by measuring the rate at which a radiolabelled solid meal leaves the stomach over a 4-hour period.- Retention of more than **10% of the meal at 4 hours** confirms delayed gastric emptying in a patient with autonomic complications of Type 1 Diabetes.*Oesophagogastroduodenoscopy with biopsy*- Primarily used to exclude **mechanical obstruction**, peptic ulcers, or **coeliac disease**, but it cannot objectively measure gastric motility.- While used as a first-line test to rule out structural issues, it will typically show a **normal gastric lumen** in cases of functional gastroparesis.*Abdominal ultrasound*- Useful for detecting **gallstones** or pyloric stenosis, but it is not sensitive or specific enough to diagnose **gastroparesis**.- It provides anatomical mapping rather than the functional **dynamic assessment** required to evaluate gastric transit time.*Hydrogen breath test*- This test is specifically used to diagnose **Small Intestinal Bacterial Overgrowth (SIBO)** or **carbohydrate malabsorption** (e.g., lactose intolerance).- While SIBO can coexist with gastroparesis due to stasis, the test does not provide information on the **rate of stomach emptying**.*Autonomic function testing*- Used to assess **cardiovascular autonomic neuropathy** (e.g., heart rate variability), which shares a common pathology with gastroparesis.- While it confirms generalized **autonomic dysfunction**, it does not provide the **organ-specific data** needed to confirm a diagnosis of gastroparesis.
Question 64: A 7-year-old boy presents with episodic events described by his teacher. During class, he suddenly becomes unresponsive for approximately 10 seconds, stares blankly, and exhibits subtle eyelid fluttering. He immediately resumes his previous activity with no post-ictal confusion. These episodes occur 5-10 times daily. An EEG shows bilateral synchronous 3 Hz spike-and-wave discharges. What is the expected response to hyperventilation during EEG testing in this condition?
- A. Provocation of typical absence seizures with 3 Hz spike-and-wave activity (Correct Answer)
- B. Development of focal sharp waves in the temporal region
- C. Appearance of hypsarrhythmia pattern
- D. No significant change in EEG pattern
- E. Emergence of polyspike-and-wave complexes at 4-6 Hz
Explanation: ***Provocation of typical absence seizures with 3 Hz spike-and-wave activity*** - **Hyperventilation** is a potent and classic precipitating factor for **childhood absence epilepsy (CAE)**, consistently inducing both the clinical staring spells and the characteristic **3 Hz spike-and-wave** discharges on EEG. - This physiological maneuver induces **hypocapnia** and subsequent **cerebral vasoconstriction**, which increases neuronal excitability and lowers the seizure threshold in genetically predisposed individuals with CAE. *Development of focal sharp waves in the temporal region* - **Focal sharp waves** localized to the temporal region are indicative of **focal epilepsy**, such as **temporal lobe epilepsy (TLE)**, not generalized absence epilepsy. - **Childhood absence epilepsy** is a **generalized epilepsy** syndrome, meaning EEG abnormalities are bilateral and synchronous, reflecting widespread cortical involvement rather than a localized origin. *Appearance of hypsarrhythmia pattern* - The **hypsarrhythmia** pattern on EEG is a hallmark of **West syndrome (infantile spasms)**, characterized by chaotic, high-amplitude slow waves and multifocal spikes. - West syndrome typically affects infants (under 1 year) and presents with specific infantile spasms and developmental regression, distinct from the clinical presentation and age of this 7-year-old with absence seizures. *No significant change in EEG pattern* - **Hyperventilation** is highly effective in activating absence seizures, provoking the characteristic EEG changes in a high percentage (around 90%) of untreated patients with **childhood absence epilepsy**. - A lack of any change in the EEG pattern during hyperventilation would argue strongly against a diagnosis of **absence epilepsy** and would prompt consideration of alternative conditions. *Emergence of polyspike-and-wave complexes at 4-6 Hz* - **Polyspike-and-wave complexes**, particularly at a faster frequency like 4-6 Hz, are the characteristic EEG findings associated with **Juvenile Myoclonic Epilepsy (JME)**. - While JME can include absence seizures, they are usually accompanied by prominent **myoclonic jerks**, typically upon awakening, and present in an older age group (adolescence) than the patient described.
Question 65: A 9-year-old boy with type 1 diabetes for 3 years attends his annual review. His blood tests show HbA1c of 58 mmol/mol. His mother reports that he has been experiencing morning hyperglycaemia despite good control during the day. His bedtime glucose readings are typically 6-8 mmol/L, but morning fasting glucose is 12-14 mmol/L. What phenomenon best explains his morning hyperglycaemia?
- A. Dawn phenomenon (Correct Answer)
- B. Somogyi effect
- C. Insulin resistance syndrome
- D. Dietary non-compliance
- E. Insufficient total daily insulin dose
Explanation: ***Dawn phenomenon***- The **Dawn phenomenon** occurs due to a natural surge in **counter-regulatory hormones** like **growth hormone** and **cortisol** in the early morning, which triggers hepatic glucose production.- It is characterized by **morning hyperglycemia** despite normal or near-normal blood glucose levels at bedtime and the absence of **nocturnal hypoglycemia**.*Somogyi effect*- This describes **rebound hyperglycemia** in the morning as a response to an undetected episode of **hypoglycemia** during the night (around 2-3 AM).- Differentiating this from the dawn phenomenon requires measuring glucose in the middle of the night; the Somogyi effect would show **low midnight glucose**, whereas dawn phenomenon would show normal or high levels.*Insulin resistance syndrome*- This refers to a systemic condition where tissues have a **diminished response** to insulin, typically associated with **Type 2 Diabetes** and obesity, not specifically isolated morning spikes.- While it can coexist with Type 1 Diabetes (Double Diabetes), it does not explain the specific **circadian pattern** of glucose rise seen in this boy.*Dietary non-compliance*- This involves inconsistent carbohydrate intake or failure to bolus for meals, which usually results in **post-prandial spikes** throughout the day rather than just a fasting morning rise.- The scenario states the patient has **good control during the day** and normal bedtime readings, which makes nocturnal dietary issues unlikely.*Insufficient total daily insulin dose*- If the total daily insulin dose were insufficient, one would expect the **HbA1c** to be significantly higher and glucose levels to be elevated **consistently throughout the day**.- Since the patient has **good daytime control** and normal bedtime readings (6-8 mmol/L), the basal-bolus balance is generally appropriate, pointing away from a global insulin deficiency.
Question 66: A 6-year-old girl with type 1 diabetes mellitus is being started on insulin therapy. Her parents ask about the onset of action of different insulin preparations. What is the approximate onset of action of insulin aspart?
- A. 5-15 minutes (Correct Answer)
- B. 30-60 minutes
- C. 1-2 hours
- D. 2-4 hours
- E. 4-6 hours
Explanation: ***5-15 minutes*** - **Insulin aspart** is a **rapid-acting** insulin analogue designed for **prandial** (mealtime) control, allowing for administration immediately before or even after eating. - Its rapid onset is due to a structural modification that prevents hexamer formation, allowing for faster absorption into the bloodstream compared to regular insulin. *30-60 minutes* - This is the typical onset of action for **Regular insulin**, which is classified as a **short-acting** insulin. - Because of this delay, Regular insulin must be administered at least **30 minutes before** a meal to match the postprandial glucose spike. *1-2 hours* - This onset of action is characteristic of **NPH (Neutral Protamine Hagedorn)**, which is an **intermediate-acting** insulin. - NPH is often used to provide basal coverage or twice-daily dosing but is not suitable for immediate mealtime glycemic control. *2-4 hours* - This time frame corresponds to the onset of **long-acting** insulin analogues such as **insulin glargine** (U-100) or **detemir**. - These insulins are used to provide stable **basal levels** of insulin throughout the day and night rather than responding to food intake. *4-6 hours* - This delay is significantly longer than any bolus or standard basal insulin, occasionally seen with very-long-acting formulations like **degludec** reaching steady states. - Using an insulin with this onset for mealtime coverage would lead to severe **post-meal hyperglycemia** followed by late-onset hypoglycemia.
Question 67: A 16-year-old boy with type 1 diabetes for 8 years presents for routine review. His HbA1c has been suboptimal at 75-82 mmol/mol over the past year despite multiple clinic appointments. He admits to frequently missing insulin doses and not checking his blood glucose regularly. He expresses frustration with diabetes management and feeling "different" from his peers. His growth and development are normal and there are no acute complications. What is the most appropriate initial approach to improve his diabetes management?
- A. Refer to child and adolescent mental health services for assessment of depression
- B. Switch to insulin pump therapy to simplify his insulin regimen
- C. Arrange urgent admission for intensive diabetes education and supervised insulin administration
- D. Explore his feelings about diabetes and collaborate on mutually agreed realistic goals (Correct Answer)
- E. Prescribe continuous glucose monitoring to reduce the burden of finger-prick testing
Explanation: ***Explore his feelings about diabetes and collaborate on mutually agreed realistic goals***- This adolescent is experiencing **diabetes burnout** and psychosocial stress, common during this developmental stage; building a **therapeutic alliance** through empathetic communication is the essential first step.- Using **motivational interviewing** to explore his frustrations and set collaborative, incremental goals significantly improves **treatment adherence** and self-management in this age group.*Refer to child and adolescent mental health services for assessment of depression*- While **depression** is more prevalent in teens with chronic illness, the primary issue described is **diabetes-related distress** and non-adherence, rather than clear diagnostic features of a clinical mood disorder.- Initial psychosocial support for diabetes burnout should ideally be provided by the **diabetes multidisciplinary team** before a specialist mental health referral is considered.*Switch to insulin pump therapy to simplify his insulin regimen*- Successful **insulin pump therapy** requires high levels of engagement, including frequent carbohydrate counting and active management, which the patient is currently struggling with.- Introducing complex **technology** without addressing underlying motivation and non-adherence often leads to increased frustration and **poor glycemic control**, potentially increasing risks like DKA.*Arrange urgent admission for intensive diabetes education and supervised insulin administration*- Urgent admission is reserved for **acute medical complications** like DKA or severe illness, not for suboptimal HbA1c in an otherwise stable patient.- Forcible supervision can be **counterproductive** in adolescents, potentially damaging their developing sense of autonomy and increasing their resistance to long-term diabetes management.*Prescribe continuous glucose monitoring to reduce the burden of finger-prick testing*- While **continuous glucose monitoring (CGM)** can reduce the physical burden of testing, it still requires the patient to actively use the data to adjust insulin, which is unlikely if he is already **missing doses**.- Technology is an important adjunct, but it cannot replace the foundational need to address the patient's **psychological barriers** and motivation to engage with their diabetes care.
Question 68: A 11-year-old boy with refractory focal epilepsy is being evaluated for possible epilepsy surgery. He has tried four different antiepileptic drugs without adequate seizure control and experiences 2-3 seizures per week affecting his school attendance and quality of life. Video-EEG telemetry has identified a consistent seizure focus in the right frontal lobe. MRI brain shows focal cortical dysplasia in the same region. Neuropsychological testing shows age-appropriate cognitive function. Which additional investigation is most critical in determining his suitability for surgical resection?
- A. Functional MRI to map eloquent cortex in relation to the dysplastic area (Correct Answer)
- B. Positron emission tomography (PET) scan to assess metabolic activity
- C. Single photon emission computed tomography (SPECT) during seizure
- D. Genetic testing for epilepsy gene mutations
- E. Repeat MRI with higher resolution 3T protocol
Explanation: ***Functional MRI to map eloquent cortex in relation to the dysplastic area*** - Since the seizure focus is already localized to the **right frontal lobe** via EEG and MRI, the priority shifts to determining the safety of resection relative to **eloquent cortex** (e.g., motor or language areas). - **fMRI** provides vital information on whether surgical removal of the **focal cortical dysplasia** can be achieved without causing permanent neurological or motor deficits. *Positron emission tomography (PET) scan to assess metabolic activity* - **PET scans** are primarily used to identify areas of **interictal hypometabolism** when structural MRI is normal or discordant with EEG. - In this case, the **seizure focus** is already well-defined by both MRI and EEG, making metabolic mapping less critical than functional mapping. *Single photon emission computed tomography (SPECT) during seizure* - **Ictal SPECT** is used to localize the seizure generator by measuring **regional cerebral blood flow** during an ictus, which is helpful in non-lesional cases. - Because a **structural lesion** (focal cortical dysplasia) has already been identified and correlates with the EEG, SPECT is not the most critical next step. *Genetic testing for epilepsy gene mutations* - **Genetic testing** can identify specific syndromes or etiologies, which may help predict pharmacological response or long-term prognosis. - While useful for diagnosis and counseling, it does not provide the **anatomical or functional mapping** required to determine the surgical feasibility of resecting a known lesion. *Repeat MRI with higher resolution 3T protocol* - A **3T MRI** is superior for detecting subtle **focal cortical dysplasia**, but the lesion in this patient has already been successfully identified. - Further high-resolution imaging will not address the primary surgical concern regarding the proximity of the **epileptogenic zone** to critical functional brain regions.
Question 69: A 4-year-old boy with newly diagnosed type 1 diabetes is being commenced on insulin therapy. His parents ask about the rationale for using rapid-acting insulin analogues (such as insulin aspart or lispro) rather than regular soluble human insulin for mealtime boluses. What is the primary pharmacokinetic advantage of rapid-acting insulin analogues in paediatric diabetes management?
- A. They have a longer duration of action allowing less frequent dosing
- B. They have more predictable absorption and reduced risk of late hypoglycaemia (Correct Answer)
- C. They do not require injection and can be administered orally
- D. They are more potent requiring lower doses per unit of carbohydrate
- E. They do not require refrigeration improving storage convenience
Explanation: ***They have more predictable absorption and reduced risk of late hypoglycaemia*** - Rapid-acting analogues (insulin aspart, lispro) have a **faster onset** and **peak action** that more closely matches post-meal glucose absorption, leading to improved glycemic control. - Their **shorter duration of action** minimizes the risk of **postprandial late hypoglycaemia**, which is crucial in children with often unpredictable eating schedules and physical activity. *They have a longer duration of action allowing less frequent dosing* - Rapid-acting insulin analogues actually have a **shorter duration of action** (typically 3-5 hours) compared to regular human insulin (6-8 hours). - This pharmacokinetic property makes them ideal for mealtime coverage, while **long-acting basal insulins** are used for less frequent dosing to cover basal needs. *They do not require injection and can be administered orally* - Insulin, being a **protein hormone**, would be inactivated and digested by **gastrointestinal enzymes** if administered orally. - All currently available insulin preparations for **Type 1 diabetes** necessitate **subcutaneous injection** or continuous infusion via a pump. *They are more potent requiring lower doses per unit of carbohydrate* - Rapid-acting insulin analogues have a **similar biological potency** per unit as regular human insulin when it comes to lowering blood glucose. - Their primary advantage is their **pharmacokinetic profile** (speed of action and duration), not an inherently higher potency that would lead to lower dose requirements. *They do not require refrigeration improving storage convenience* - Like all insulin preparations, rapid-acting analogues **require refrigeration** for long-term storage to maintain their stability and efficacy. - While in use, they can be kept at **room temperature** for a limited time (usually 28 days), which is similar to the storage requirements for regular human insulin and not a unique advantage.
Question 70: A 15-year-old girl with juvenile myoclonic epilepsy has been well-controlled on sodium valproate 800 mg twice daily for 3 years. She attends clinic with her mother requesting information about future pregnancy planning. She is not currently sexually active. Understanding the teratogenic risks, which counseling point regarding valproate and pregnancy is most accurate?
- A. Folic acid supplementation at standard doses (400 micrograms daily) eliminates the risk of neural tube defects
- B. The risk of major congenital malformations with valproate exposure is approximately 10% (Correct Answer)
- C. Valproate can be safely continued if conception is avoided during periods of high seizure frequency
- D. Switching to lamotrigine before any pregnancy is planned eliminates all teratogenic risk
- E. Developmental disorders in offspring occur only when major malformations are present
Explanation: ***The risk of major congenital malformations with valproate exposure is approximately 10%***- **Sodium valproate** carries the highest risk among antiepileptic drugs, with malformations occurring in about **10%** of pregnancies compared to 2–3% in the general population.- This high rate of **teratogenicity** is a primary reason for the strict regulations regarding its use in females of childbearing potential.*Folic acid supplementation at standard doses (400 micrograms daily) eliminates the risk of neural tube defects*- High-dose **folic acid (5 mg daily)** is required for women on antiepileptics, but it only **reduces** rather than eliminates the risk of **neural tube defects**.- Valproate-associated risks extend beyond neural tube defects to include **cardiac anomalies** and orofacial clefts which folic acid does not fully prevent.*Valproate can be safely continued if conception is avoided during periods of high seizure frequency*- The risk of **malformations** is associated with valproate exposure during the **first trimester** (organogenesis), regardless of seizure frequency at the time of conception.- Current **MHRA guidance** mandates that valproate must not be used in women of childbearing potential unless a **Pregnancy Prevention Programme** is in place.*Switching to lamotrigine before any pregnancy is planned eliminates all teratogenic risk*- While **lamotrigine** has a lower risk profile (2–3%), no antiepileptic drug is considered to have **zero teratogenic risk**.- Switching must be balanced against the risk of **seizure recurrence**, particularly as **Juvenile Myoclonic Epilepsy** often responds poorly to drugs other than valproate.*Developmental disorders in offspring occur only when major malformations are present*- Valproate exposure is associated with **neurodevelopmental delay** in 30–40% of children, which can occur **independently** of physical malformations.- These issues include a lower **IQ**, delays in walking and talking, and increased risks of **Autism Spectrum Disorder** or ADHD.
Practice by Chapter
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free